Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis

Clinical trial NCT05700266 · UNKNOWN

Trial details

NCT number: NCT05700266
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke Intracranial Atherosclerosis Stenosis

Start date: 2023-12-30
Primary completion: 2024-12-01
Enrollment: 1180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.